Showing results (31-40 of 45) with videos related to
Sort By:
Pageof 5
Molecular Informatics|November 19, 2016
Combined Simulation and Mutation Studies to Elucidate Selectivity of Unsubstituted Amphetamine-like Cathinones at the Dopamine TransporterAmir Seddik, Daan P Geerke, Thomas Stockner, et al.European Journal of Pharmacology|November 27, 2012
Pharmacological examination of trifluoromethyl ring-substituted methcathinone analogsNicholas V Cozzi, Simon D Brandt, Paul F Daley, et al.Journal of the Neurological Sciences|April 6, 2024
Psilocybin pulse regimen reduces cluster headache attack frequency in the blinded extension phase of a randomized controlled trialEmmanuelle A D Schindler, R Andrew Sewell, Christopher H Gottschalk, et al.ACS Omega|July 21, 2020
Direct Phosphorylation of Psilocin Enables Optimized cGMP Kilogram-Scale Manufacture of PsilocybinRobert B Kargbo, Alexander Sherwood, Andrew Walker, et al.Journal of Chemical Neuroanatomy|February 7, 2017
Atypical dopamine efflux caused by 3,4-methylenedioxypyrovalerone (MDPV) via the human dopamine transporterAparna Shekar, Jenny I Aguilar, Greta Galli, et al.Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|November 13, 2020
Exploratory Controlled Study of the Migraine-Suppressing Effects of PsilocybinEmmanuelle A D Schindler, R Andrew Sewell, Christopher H Gottschalk, et al.Journal of Psychopharmacology (Oxford, England)|June 28, 2018
High dose psilocybin is associated with positive subjective effects in healthy volunteersChristopher R Nicholas, Kelsey M Henriquez, Michele C Gassman, et al.British Journal of Pharmacology|December 3, 2014
Quantitative structure-activity relationship analysis of the pharmacology of para-substituted methcathinone analoguesJ S Bonano, M L Banks, R Kolanos, et al.Headache|November 23, 2022
Exploratory investigation of a patient-informed low-dose psilocybin pulse regimen in the suppression of cluster headache: Results from a randomized, double-blind, placebo-controlled trialEmmanuelle A D Schindler, R Andrew Sewell, Christopher H Gottschalk, et al.Neuropharmacology|April 28, 2019
para-Trifluoromethyl-methcathinone is an allosteric modulator of the serotonin transporterMarco Niello, Daniela Cintulova, Eva Hellsberg, et al.Pageof 5